Genetic disruption or pharmacologic inhibition of sEH led to an enhancement of insulin signaling and sensitivity, increased islet size and vasculature, and decreased plasma glucose.447 sEH knockout or inhibition not only attenuated insulin resistance in diabetes but also enhanced glucose-stimulated insulin secretion from islet cells and decreased islet cell apoptosis. The gene discussed is INS; the disease is diabetes mellitus.